Article

Hepatitis C virus seroprevalence among haemodialysis patients, sickle cell patients and blood donors at a tertiary hospital in Yaounde, Cameroon

Published in: Southern African Journal of Infectious Diseases
Volume 33 , issue 1 , 2018 , pages: 1–3

DOI: 10.1080/23120053.2017.1349065

Author(s): Therese Ndomgue Department of Microbiology/Immunology, Cameroon , Michel Kengne Department of Microbiology/Immunology, Cameroon , Patrick Achiangia Njukeng Department of Plant Biology, Cameroon , Valentine Ngum Ndze Metabiota Cameroon, Cameroon , Damien Nota Anong Department of Microbiology and Parasitology, Cameroon , Tracy Madimabi Masebe Department of Life and Consumer Sciences, South Africa , Ubald Tamoufe Metabiota Cameroon, Cameroon , Anastasia Yenban Bongajum Service for the prevention of mother-to-child transmission of HIV (PMTCT), Cameroon , Daniel Ter Goon Department of Nursing Sciences, South Africa , Julius Mbekem Nwobegahay Military Health Research Center (CRESAR), Cameroon

Keywords: Blood donors , HCV antibodies , haemodialysis , hepatitis C virus , seroprevalence , sickle cell

Download full text Get new issue alerts

Abstract

Background: Hepatitis C virus (HCV) infection is a serious health care problem in haemodialysis patients, sickle cell patients and blood donation in Africa. However, there is a paucity of information about this in Cameroon. This study presents the prevalence of antibodies to HCV among haemodialysis patients, sickle cell patients and blood donors at the Yaounde University Teaching Hospital, Cameroon.

« Crimean-Congo haemorrhagic fever presenting with undiagnosed chronic myeloid leukaemia

Recommendations for the use of meningococcal vaccines in South Africa »